Mobile Menu

Bringing the Benefits of Genomics to Everyone – Genomics England’s Efforts in 2022 and Beyond


Bringing the Benefits of Genomics to Everyone – Genomics England’s Efforts in 2022 and Beyond
Chris Wigley, Chief Executive Officer, Genomics England

You may also like

Combining long and short read sequencing
Andrew Beggs, Mike Hubank and Matt Loose
Applications of RNA-seq for infectious disease research
Jose Afonso Guerra-Assuncao, Research Associate, UCL
Spatial and temporal RNA-sequencing
Sam Rodriques, Group Leader, Francis Crick Institute
Mapping immune cells in tissues using single cell and spatial genomics
Sarah Teichmann, Cellular Genetics Programme Head, Wellcome Sanger Institute
Liquid biopsy: From discovery to clinical implementation
Klaus Pantel, Chairman of the Institute of Tumour Biology, University Centre Hamburg-Eppendorf
Cancer evolution, immune evasion and metastasis
Charles Swanton, Senior Group Leader, Crick Institute
Molecular diagnostics and the NHSE Long Term Plan for Cancer
Peter Johnson, National Clinical Director for Cancer, NHS England
Translating germline cancer genomics into precision prevention of cancer
Clare Turnbull, Professor of Translational Cancer Genetics, Institute of Cancer Research
Drugging the cancer genome: progress, opportunities and challenges in personalised medicine
Paul Workman, Professor of Pharmacology and Therapeutics, Institute of Cancer Research
Genomics for better health
Featuring speakers from GSK and the University of Oxford

Page 1 of 2